AMD Research Breakthrough: New Insights into Protecting Your Vision

Recent research into age-related macular degeneration (AMD) is offering new insights into how we may better protect our vision as we age.

In a webinar hosted by the Macular Society, Professor Andrew Dick discussed groundbreaking research exploring the role of mitochondria in retinal health.

Understanding the Link Between Mitochondria and Eye Health

In the retina, mirochondria provide the essential energy needed for healthy vision. When mitochondria become damaged or less efficient, retinal cells can begin to deteriorate, contributing to conditions such as AMD.

As we age, the body’s immune system becomes less effective at regulating inflammation. This can lead to chronic inflammation, oxidative stress, and mitochondrial dysfunction — all of which are thought to play a major role in the progression of AMD.

Promising Discovery in AMD Research

Professor Dick’s research has identified a specific protein called IRAK-M, which appears to play a crucial protective role within the retina, particularly in the retinal pigment epithelium (RPE).

The study found that levels of IRAK-M naturally decline with age and are further reduced by oxidative stress and AMD itself. This loss may contribute to increased inflammation, mitochondrial damage, and retinal cell death.

Encouragingly, the research also suggests that restoring IRAK-M levels may help reduce retinal cell damage and slow disease progression. While further studies are needed, this represents an exciting development in our understanding of AMD and future treatment possibilities.

How Can You Protect Your Eye Health?

While research continues, there are several practical steps we can all take to support retinal and mitochondrial health:

• Wear quality sunglasses to reduce UV exposure
• Avoid smoking
• Drink alcohol in moderation
• Maintain a healthy, balanced diet rich in antioxidants
• Attend regular eye examinations

The Role of Photobiomodulation

At our practice, we also offer the Valeda Light Delivery System treatment, which uses photobiomodulation technology to support retinal cell function. This non-invasive treatment aims to improve cellular energy production and reduce oxidative stress within the retina.

As research into AMD continues to advance, developments such as these provide growing hope for protecting vision and improving quality of life for patients living with macular disease.

Want to Learn More About The Research?

Listen to the Macular Society webinar featuring Professor Andrew Dick.

Find Out More About AMD Treatment at Elizabeth Evans Opticians

Discover more about Valeda Light Therapy, photobiomodulation and treatment for dry AMD, including how the treatment works and whether you may be suitable.

If you have any questions about macular degeneration, Valeda Light Therapy or your suitability for treatment, please make an enquiry here or call 01661 832 564 – our friendly team will be happy to help.